AU Patent

AU2004311880B2 — Generally linear effervescent oral fentanyl dosage form and methods of administering

Assigned to Phoenix Labs Unlimited Co · Expires 2010-08-05 · 16y expired

What this patent protects

Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fen…

USPTO Abstract

Fentanyl containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than know oral formulation and have advantages in terms of cost and side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004311880B2
Jurisdiction
AU
Classification
Expires
2010-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Phoenix Labs Unlimited Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.